Metabio

The complexity of the electronic systems, currently used by biobanks, create delays, non-uniformity and segmentation of their services. Until recently, these systems were considered adequate due to the low volume of data collection and storage associated to biosamples that were proportional to demand. But in recent years, data collections have expanded in biobanks worldwide due to growing demand. Although the level of mechanical equipment (strong cooling chambers) is very satisfactory, operating systems simply increased without interoperability in mind, leaving many of the bio-samples either out of demand or out of stock. The METABIO platform consists of four interoperable systems namely e-MetaBank® for biobanks, e-MetaHealth® for donor patients, e-MetaHep® for hospitals, clinics, doctors and e-MetaRes® for researchers and research centers. The e-MetaBio® interoperable system works seamlessly with existing systems, even legacy ones, either through API connection and direct operation or through a customized action model, without the need or requirement to change the current LIMS / LMS system or other applicable platforms used. With the e-MetaBio platform, data are recorded and integrated from every step during the biosample usage chain, creating a chain of fully characterized, relational timeline data per donor and biosample. Thus, the research centers reduce their operating time and consequently their operating costs, while the biobanks give surplus value and availability to the growing demand for biosamples, without the demand being a problem due to the malfunction of electronic systems. Finally, we create procedures for retrospective audits of collections, to ensure that we follow and positively influence the needs of biobanks, in the context of development.
We jointly work with biobanks to determine their KPIs and create their recording methods in order to upgrade them. With e-MetaBio the number and value of biological samples collected i) increase the scope of research participation spectrum,
ii) reduce the cycle of biosample supply,
iii) increase the number of biosample searches through the platform
iv) increase the number of scientific publications
v) decrease administrative costs per project
vi) increase the depth of biosample annotation.
The innovation of the platform and services can be summarized in the following:
1. Offering interoperability between systems in the biosample usage chain,
2. Creating bio-samples with harmonized and standardized data,
3. Use of Dynamic and Real-time Tiered consent
4. Real time digital search for profiles of biosamples and patients, through multi-criteria searches,
5. Creation of biosamples with longitudinal data from multiple sources
6. Patient-pushed Real-World data
Furthermore, the e-MetaBio platform has the potential to expand into more specialized areas of medicine and health services. We have already completed the extension of e-MetaHep® and e-MetaHealth® to the e-embryo application, an application for Obstetricians – gynecologists and pregnant women respectively. The result of the application is the historical recording and storage of medical data (by the doctor) but also by the pregnant woman, recording the developmental activity of the fetus in the environment of the uterus and the development of the newborn with all known methodological elements.
All Metabio’s services follow European legislation on personal data, GDPR. This gives the advantage of extending e-consent to more market segments, where although basic principles of legislation are followed, it does not follow all the requirements that are produced. Objectives for the development of e-consent to public and private organizations, banks, insurance companies, telecommunications, etc.